Ageing Improves the Antioxidant Response Against Postoperative Atrial Fibrillation: a Randomized Controlled Trial

Overview

Journal Interact Cardiovasc Thorac Surg

Publisher Oxford University Press

Specialties Cardiology & Vascular Diseases
General Surgery
Pulmonary Medicine

Date 2012 May 8

PMID 22561296

Citations 17

Authors

Ramon Rodrigo

Rodrigo Gutierrez

Rodrigo Fernandez

Pablo Guzman

Affiliations

Soon will be listed here.

Abstract

Objectives: Extracorporeal circulation is associated with ischaemia-reperfusion-induced oxidative stress and atrial fibrillation (AF). Ageing is the major risk factor for this arrhythmia. Reinforcing the antioxidant defence system would be expected to protect the myocardium against ischaemia-reperfusion damage. We studied the effect of antioxidant reinforcement and ageing on the occurrence of postoperative AF.

Methods: A randomized, double-blind, placebo-controlled trial was performed in patients scheduled for cardiac surgery with extracorporeal circulation. Supplementation with omega-3 polyunsaturated fatty acid (PUFA) and vitamins C and E, or placebo was administered to 152 patients divided by age: young patients (30-59 years) and old patients (60-80 years). For the detection of AF, we used 12-lead and Holter EKGs. Antioxidant enzyme activity was determined in atrial tissue. Oxidative stress was assessed through plasma malondialdehyde levels.

Results: Supplemented patients over 60 years old showed higher glutathione peroxidase activity than control patients in the same age range. There was no difference between the supplemented and placebo groups in patients under 60 years old. The decrease in the incidence of postoperative AF in supplemented patients was more marked in the older patients than in the younger ones.

Conclusions: Since the antioxidant supplementation with n-3 PUFAs and vitamins C and E resulted in a more marked reduction of postoperative AF in older patients, it could be suggested that the efficacy of this therapy improves with ageing.

Citing Articles

Targeted nutritional strategies in postoperative care.

Ham H, Kim J Anesth Pain Med (Seoul). 2025; 20(1):34-45.

PMID: 39809503 PMC: 11834873. DOI: 10.17085/apm.24067.

Preoperative and postoperative administration of vitamin C in cardiac surgery patients - settings, dosages, duration, and clinical outcomes: a narrative review.

Athanasiou A, Charalambous M, Anastasiou T, Aggeli K, Soteriades E Ann Med Surg (Lond). 2024; 86(6):3591-3607.

PMID: 38846824 PMC: 11152825. DOI: 10.1097/MS9.0000000000002112.

Potential Role of Natural Antioxidants in Countering Reperfusion Injury in Acute Myocardial Infarction and Ischemic Stroke.

Orellana-Urzua S, Briones-Valdivieso C, Chichiarelli S, Saso L, Rodrigo R Antioxidants (Basel). 2023; 12(9).

PMID: 37760064 PMC: 10525378. DOI: 10.3390/antiox12091760.

A Genotype-Phenotype Analysis of Glutathione Peroxidase 4 in Human Atrial Myocardium and Its Association with Postoperative Atrial Fibrillation.

Berdaweel I, Hart A, Jatis A, Karlan N, Akhter S, Gaine M Antioxidants (Basel). 2022; 11(4).

PMID: 35453406 PMC: 9026099. DOI: 10.3390/antiox11040721.

Novel Combined Antioxidant Strategy against Hypertension, Acute Myocardial Infarction and Postoperative Atrial Fibrillation.

Rodrigo R, Gonzalez-Montero J, Sotomayor C Biomedicines. 2021; 9(6).

PMID: 34070760 PMC: 8228412. DOI: 10.3390/biomedicines9060620.

References

Mendoza-Nunez V, Ruiz-Ramos M, Sanchez-Rodriguez M, Retana-Ugalde R, Munoz-Sanchez J . Aging-related oxidative stress in healthy humans. Tohoku J Exp Med. 2007; 213(3):261-8. DOI: 10.1620/tjem.213.261. View

Calo L, Bianconi L, Colivicchi F, Lamberti F, Loricchio M, De Ruvo E . N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol. 2005; 45(10):1723-8. DOI: 10.1016/j.jacc.2005.02.079. View

Saravanan P, Bridgewater B, West A, ONeill S, Calder P, Davidson N . Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. Circ Arrhythm Electrophysiol. 2010; 3(1):46-53. DOI: 10.1161/CIRCEP.109.899633. View

Korantzopoulos P, Kolettis T, Galaris D, Goudevenos J . The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol. 2006; 115(2):135-43. DOI: 10.1016/j.ijcard.2006.04.026. View

Van Wagoner D . Molecular basis of atrial fibrillation: a dream or a reality?. J Cardiovasc Electrophysiol. 2003; 14(6):667-9. DOI: 10.1046/j.1540-8167.2003.03070.x. View

Castillo R, Rodrigo R, Perez F, Cereceda M, Asenjo R, Zamorano J . Antioxidant therapy reduces oxidative and inflammatory tissue damage in patients subjected to cardiac surgery with extracorporeal circulation. Basic Clin Pharmacol Toxicol. 2010; 108(4):256-62. DOI: 10.1111/j.1742-7843.2010.00651.x. View

Dai D, Rabinovitch P . Cardiac aging in mice and humans: the role of mitochondrial oxidative stress. Trends Cardiovasc Med. 2010; 19(7):213-20. PMC: 2858758. DOI: 10.1016/j.tcm.2009.12.004. View

Jahangiri A, Leifert W, Kind K, McMurchie E . Dietary fish oil alters cardiomyocyte Ca2+ dynamics and antioxidant status. Free Radic Biol Med. 2006; 40(9):1592-602. DOI: 10.1016/j.freeradbiomed.2005.12.026. View

Rodrigo R, Vinay J, Castillo R, Cereceda M, Asenjo R, Zamorano J . Use of vitamins C and E as a prophylactic therapy to prevent postoperative atrial fibrillation. Int J Cardiol. 2009; 138(3):221-8. DOI: 10.1016/j.ijcard.2009.04.043. View

10.

Rodrigo R, Cereceda M, Castillo R, Asenjo R, Zamorano J, Araya J . Prevention of atrial fibrillation following cardiac surgery: basis for a novel therapeutic strategy based on non-hypoxic myocardial preconditioning. Pharmacol Ther. 2008; 118(1):104-27. DOI: 10.1016/j.pharmthera.2008.01.005. View

11.

Oral H . Post-operative atrial fibrillation and oxidative stress: a novel causal mechanism or another biochemical epiphenomenon?. J Am Coll Cardiol. 2008; 51(1):75-6. DOI: 10.1016/j.jacc.2007.09.025. View

12.

Van Wagoner D . Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target. J Cardiovasc Pharmacol. 2008; 52(4):306-13. DOI: 10.1097/FJC.0b013e31817f9398. View

13.

Zaman A, Archbold R, Helft G, Paul E, Curzen N, Mills P . Atrial fibrillation after coronary artery bypass surgery: a model for preoperative risk stratification. Circulation. 2000; 101(12):1403-8. DOI: 10.1161/01.cir.101.12.1403. View

14.

Mariscalco G, Braga S, Banach M, Borsani P, Bruno V, Napoleone M . Preoperative n-3 polyunsatured fatty acids are associated with a decrease in the incidence of early atrial fibrillation following cardiac surgery. Angiology. 2010; 61(7):643-50. DOI: 10.1177/0003319710370962. View

15.

Laurent G, Moe G, Hu X, Holub B, Leong-Poi H, Trogadis J . Long chain n-3 polyunsaturated fatty acids reduce atrial vulnerability in a novel canine pacing model. Cardiovasc Res. 2007; 77(1):89-97. DOI: 10.1093/cvr/cvm024. View